logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

HR+ breast cancer: study nixes link between lower BMD and better survival

Prospective cohort within the phase 3 DATA trial comparing 6 vs 3 years of anastrozole.